Načítá se...
Immunotherapy Discontinuation in Metastatic Melanoma: Lessons from Real-Life Clinical Experience
SIMPLE SUMMARY: Metastatic melanoma patients derive unprecedented benefit from immunotherapy, and some of them are even considered cured. Currently, there is no consensus on the safety nor on the timing of treatment discontinuation in this population. This is a real-world study on 106 advanced melan...
Uloženo v:
| Vydáno v: | Cancers (Basel) |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8234591/ https://ncbi.nlm.nih.gov/pubmed/34203061 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13123074 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|